0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Minimum Requirements for Renal Biopsy Size for Patients with IgA Nephropathy

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In order to clarify the minimum requirements for renal biopsy size for a more accurate interpretation of renal biopsy information by light microscopy, we reanalyzed 92 open renal biopsy specimens in 92 patients with IgA nephropathy retrospectively. The mean number of functioning glomeruli per square millimeter in open renal biopsy specimens from 38 patients with a poor outcome was 1.2 ± 0.4. In contrast, the mean number in 54 biopsy specimens from 54 patients with stable conditions for 10 years was 3.0 ± 0.6. Therefore, there was a significant reduction (p < 0.0001) in the numbers of functioning glomeruli in patients with a poor outcome. We found that the most important point in predicting the severity of tissue damage was detection not of the total numbers of glomeruli but of the density of glomeruli in given specimens in patients with IgA nephropathy. A biopsy sample of 1 mm × 7 mm in size of cortical origin is the minimum necessary to confidently interpret biopsy specimens from patients with IgA nephropathy.

          Related collections

          Author and article information

          Journal
          NEF
          Nephron
          10.1159/issn.1660-8151
          Nephron
          S. Karger AG
          1660-8151
          2235-3186
          1992
          1992
          11 December 2008
          : 60
          : 2
          : 171-175
          Affiliations
          Department of Internal Medicine, School of Medicine, Tokai University, Isehara City, Kanagawa-ken, Japan
          Article
          186734 Nephron 1992;60:171–175
          10.1159/000186734
          1553001
          © 1992 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Categories
          Original Paper

          Cardiovascular Medicine, Nephrology

          Glomerulonephritis, IgA nephropathy, Kidney biopsy, Glomerulus

          Comments

          Comment on this article